Invea Therapeutics, Inc. stands as a clinical-stage biopharmaceutical firm that harnesses artificial intelligence (AI) methodologies to craft revolutionary pharmaceuticals in the fields of neuroscience and immuno-oncology.
The information provided in this document reflects the company’s individual perspective and is subject to potential changes without prior notice. The company holds no responsibility for any investment choices made by its readers or subscribers. It is strongly advisable that any decisions regarding purchases or sales be thoroughly discussed with a financial advisor, broker-dealer, or a member of a financial regulatory body.
The content presented here is offered solely as an informational service. While efforts have been made to ensure accuracy, the reliability of the information is dependent on the sources from which it was gathered and is not guaranteed. Investors are cautioned that they face the possibility of losing all or a portion of their investment in this company or any other.
The information provided here includes “forward-looking statements” as defined by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements encompass predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, and future events or performance, but are not rooted in historical facts and can be considered “forward-looking statements.” Such statements rely on expectations, estimates, and projections at the time they are articulated, and involve numerous risks and uncertainties that could lead to actual results or events differing significantly from present anticipations.
Identification of forward-looking statements may occur through terms like “expects,” “will,” “plans,” “anticipates,” “estimates,” “believes,” or indications of potential actions such as “may,” “could,” “should,” or “might.” Additionally, statements or information that reference expectations, beliefs, plans, projections, objectives, performance, or other attributes of future events or circumstances, including underlying assumptions, are considered forward-looking.
The company may not achieve its expectations, and its beliefs might not prove accurate; actual results could substantially diverge from the forward-looking statements due to various critical factors, including those noted under the “Risk Factors” section in the company’s submissions to the SEC. These factors could evolve over time. Except as required by law, the company renounces any obligation to update these forward-looking statements, and they should not be relied upon as representing the company’s stance past the date of their creation.